KATALYST Life Sciences

Active

Private limited companyfounded 2020active for 5 yearsRue Strivay(PLX) 112, 4122 Neupré, BelgiumKBO/BCE: BE 0760.501.477

Summary

KATALYST Life Sciences has been active since 2020 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €317,784 and a net result of -€6,729. Equity is growing by about 20% per year across the filed financial years. Its solvency ranks better than 95% of 609 sector peers (NACE 72, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow Report Compare

KATALYST Life SciencesActiveChecked score 90/100

Risk analysis Report Compare

History

KATALYST Life Sciences was incorporated on 23 December 2020 as a private limited company.¹ The registered office was moved to Neupré in 2026.² Total assets rose from €131,332 in 2021 to €320,875 in 2025.³

Acts, filings and financial milestones

All 12Financial 6Gazette 1Filings 5

Next filing, financial year 2026, expected by 31-07-2027

2026

18-08

NBB filing Annual accounts filed

financial year 2025 · micro format · 18 days late

06-02

Gazette deed Registered office

Registered-office move2 facts ▸

General meeting, 07-01-2026
Registered-office move, 4122 Neupré, Rue Strivay n°112

2025

31-12

Financial Weakest financial yearnet -€6,729

Net result drops to -€6,729, the lowest in the series.

31-12

Financial Liquidity more than 14 timescurrent ratio 101.79

Current ratio from 7.02 to 101.79; short-term debt falls from €52,733 to €3,091.

05-08

NBB filing Annual accounts filed

financial year 2024 · micro format · 5 days late

2024

28-09

NBB filing Annual accounts filed

financial year 2023 · micro format · 59 days late

2023

31-12

Financial Highest result from 2021 to 2025net €131,797 ▲29.9%

Operating result €196,993, net result €131,797, both a record.

31-12

Financial Equity above €200,000equity €315,599 ▲71.7%

A profit in every financial year since 2021 builds equity to €315,599.

08-08

NBB filing Annual accounts filed

financial year 2022 · micro format · 8 days late

2022

31-12

Financial Liquidity doublescurrent ratio 4.31

Current ratio from 2.14 to 4.31.

31-12

Financial Equity above €150,000equity €183,801 ▲123%

A profit in every financial year since 2021 builds equity to €183,801.

21-08

NBB filing Annual accounts filed

financial year 2021 · micro format · 21 days late

Financial milestoneGazette deedNBB filingFinancial milestones sit on the financial year-end date, not the filing date.

1 of 2 deeds read

About the unread acts

Of the 2 Belgian Official Gazette deeds we know for this company, 1 has been read. The other one has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.